Carré, Alexandre
Klausner, Guillaume
Edjlali, Myriam
Lerousseau, Marvin
Briend-Diop, Jade
Sun, Roger
Ammari, Samy
Reuzé, Sylvain
Alvarez Andres, Emilie
Estienne, Théo
Niyoteka, Stéphane
Battistella, Enzo
Vakalopoulou, Maria
Dhermain, Frédéric
Paragios, Nikos
Deutsch, Eric
Oppenheim, Catherine
Pallud, Johan
Robert, Charlotte
Funding for this research was provided by:
ITMO PhysiCancer
Amazon Web Services
Maurice Tubiana’s Grant 2018
Fondation pour la Recherche Médicale (DIC20161236437)
Article History
Received: 9 November 2019
Accepted: 6 July 2020
First Online: 23 July 2020
Competing interests
: ED reports grants and personal fees from Roche Genentech; grants from Servier; grants from AstraZeneca; grants and personal fees from Merck Serono; grants from BMS; and grants from MSD outside the submitted work. NP is CEO and founder of TheraPanacea. SR has been a full-time employee of GE Healthcare since December 2018, after his contribution to this study. EAA is in contract with TheraPanacea under a CIFRE fellowship (2017/0974).